JeffreyABogartMD

Radiation Oncology • Syracuse, NY

Professor of Radiation Oncology, SUNY Upstate Med University

Join to view full profile

Dr. Bogart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bogart's full profile

Already have an account?

Office
1000 E Genesee St
Ste 101
Syracuse, NY 13210
Phone+1 315-476-3535

Fax+1 315-476-4140

Education & Training

SUNY Upstate Medical UniversityResidency, Radiation Oncology, 1990 - 1993
University of MarylandInternship, Internal Medicine, 1989 - 1990
SUNY Upstate Medical UniversityClass of 1989

Certifications & Licensure

CA State Medical License 1993 - 2026
NY State Medical License 1992 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013

Clinical Trials

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction Start of enrollment: 2000 Dec 01
Completed
Phase 1
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2005 Sep 01
Completed
Phase 2
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2007 Nov 01
Completed
Phase 3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy Start of enrollment: 2014 Apr 01
Completed
Phase 2
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer Start of enrollment: 2015 Jul 01
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1310 citations
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...
Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
The Lancet. Oncology. 2015-02-01
261 citations
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
Journal of Clinical Oncology. 2020-03-01
149 citations
Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lu...
Ramaswamy Govindan, Jeffrey A. Bogart, Thomas E. Stinchcombe, Xiaofei Wang, Lydia Hodgson
Journal of Clinical Oncology. 2011-08-10

Journal Articles

Clinical Outcomes Following Advanced Respiratory Motion Management (Respiratory Gating or Dynamic Tumor Tracking) with Stereotactic Body Radiation Therapy for Stage I ...
Rishabh Chaudhari, Paul Aridgides, Jeffrey Bogart, Tamara Nsouli, Lung Cancer: Targets and Therapy

Press Mentions

GYN Oncology of Central New York Joins UpstateSeptember 23rd, 2019
Oswego Health Honors Its Physicians at Doctor’s Day DinnerApril 15th, 2019
Stage I Lung Cancer: Treatment Advances Have Changed the GameApril 25th, 2017
Join now to see all

Committees

Member, Definitive and Adjuvant Radiotherapy in Locally Advanced Non-small Cell Lung Cancer Guideline Panel, American Society for Radiation Oncology 2015 - Present